Integrated Genomic and Single‐Cell Analysis Reveals Heterogeneity, Prognosis, and Treatment Vulnerability in Urothelial Carcinoma
Chaozhi Tang, Yifan Liu, Tian-Long Wang, Jiakang Ma, Weihua Chen, Xiang Liu, Jingdong Xue, Lin Ye, Feng Yue · 2026
Read Integrated Genomic and Single‐Cell Analysis Reveals Heterogeneity, Prognosis, and Treatment Vulnerability in Urothelial Carcinoma by Chaozhi Tang, Yifan Liu, Tian-Long Wang, Jiakang Ma, Weihua Chen, Xiang Liu, Jingdong Xue, Lin Ye, Feng Yue (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13213714.txt.
Description
Chaozhi Tang and colleagues sort bladder-area cancers in 2026 into two types defined by their mutation patterns rather than by gene activity alone. Earlier classifications based on RNA left the genomic side of this varied cancer without a unified scheme.
Across six patient cohorts, the second subtype consistently carried higher death risk and answered immunotherapy less often. Tumour samples from that group held more cancer-supporting fibroblasts and fewer immune attacker cells under single-cell analysis. Response gaps appeared clearly in two immunotherapy cohorts, where the first subtype responded at roughly double the rate. A mutation-based split, the authors argue, could help predict who benefits from immune treatment.
Catalog record
| CREATOR | Chaozhi Tang, Yifan Liu, Tian-Long Wang, Jiakang Ma, Weihua Chen, Xiang Liu, Jingdong Xue, Lin Ye, Feng Yue |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |